Yoshida J - Search Results

1

IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide.

Natsume A, Ishii D, Wakabayashi T, Tsuno T, Hatano H, Mizuno M, Yoshida J. Natsume A, et al. Among authors: yoshida j. Cancer Res. 2005 Sep 1;65(17):7573-9. doi: 10.1158/0008-5472.CAN-05-0036. Cancer Res. 2005. PMID: 16140920

2

[Glioma].

Wakabayashi T, Natsume A, Yoshida J. Wakabayashi T, et al. Among authors: yoshida j. Nihon Rinsho. 2006 Jul;64(7):1327-32. Nihon Rinsho. 2006. PMID: 16838652 Review. Japanese.

3

A combination of IFN-beta and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation.

Natsume A, Wakabayashi T, Ishii D, Maruta H, Fujii M, Shimato S, Ito M, Yoshida J. Natsume A, et al. Among authors: yoshida j. Cancer Chemother Pharmacol. 2008 Apr;61(4):653-9. doi: 10.1007/s00280-007-0520-x. Epub 2007 Jun 13. Cancer Chemother Pharmacol. 2008. PMID: 17564708

4

Inhibition of Aurora-B function increases formation of multinucleated cells in p53 gene deficient cells and enhances anti-tumor effect of temozolomide in human glioma cells.

Tsuno T, Natsume A, Katsumata S, Mizuno M, Fujita M, Osawa H, Nakahara N, Wakabayashi T, Satoh Y, Inagaki M, Yoshida J. Tsuno T, et al. Among authors: yoshida j. J Neurooncol. 2007 Jul;83(3):249-58. doi: 10.1007/s11060-007-9335-1. Epub 2007 Feb 14. J Neurooncol. 2007. PMID: 17570035

5

Efficacy of temozolomide is correlated with 1p loss and methylation of the deoxyribonucleic acid repair gene MGMT in malignant gliomas.

Ishii D, Natsume A, Wakabayashi T, Hatano H, Asano Y, Takeuchi H, Shimato S, Ito M, Fujii M, Yoshida J. Ishii D, et al. Among authors: yoshida j. Neurol Med Chir (Tokyo). 2007 Aug;47(8):341-9; discussion 350. doi: 10.2176/nmc.47.341. Neurol Med Chir (Tokyo). 2007. PMID: 17721049 Free article.

6

A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy.

Wakabayashi T, Natsume A, Hashizume Y, Fujii M, Mizuno M, Yoshida J. Wakabayashi T, et al. Among authors: yoshida j. J Gene Med. 2008 Apr;10(4):329-39. doi: 10.1002/jgm.1160. J Gene Med. 2008. PMID: 18220319 Clinical Trial.

7

The DNA demethylating agent 5-aza-2'-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma.

Natsume A, Wakabayashi T, Tsujimura K, Shimato S, Ito M, Kuzushima K, Kondo Y, Sekido Y, Kawatsura H, Narita Y, Yoshida J. Natsume A, et al. Among authors: yoshida j. Int J Cancer. 2008 Jun 1;122(11):2542-53. doi: 10.1002/ijc.23407. Int J Cancer. 2008. PMID: 18240144

8

Epigenetic aberrations and therapeutic implications in gliomas.

Natsume A, Kondo Y, Ito M, Motomura K, Wakabayashi T, Yoshida J. Natsume A, et al. Among authors: yoshida j. Cancer Sci. 2010 Jun;101(6):1331-6. doi: 10.1111/j.1349-7006.2010.01545.x. Epub 2010 Mar 15. Cancer Sci. 2010. PMID: 20384628 Free PMC article. Review.

9

Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-beta gene therapy for malignant glioma in an experimental mouse intracranial glioma.

Saito R, Mizuno M, Nakahara N, Tsuno T, Kumabe T, Yoshimoto T, Yoshida J. Saito R, et al. Among authors: yoshida j. Int J Cancer. 2004 Sep 20;111(5):777-82. doi: 10.1002/ijc.20331. Int J Cancer. 2004. PMID: 15252850

10

Interferon-beta gene therapy for cancer: basic research to clinical application.

Yoshida J, Mizuno M, Wakabayashi T. Yoshida J, et al. Cancer Sci. 2004 Nov;95(11):858-65. doi: 10.1111/j.1349-7006.2004.tb02194.x. Cancer Sci. 2004. PMID: 15546502 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,426 results

Search Page

Filters